3D-QSAR studies and pharmacophore identification of AT1 receptor antagonists

被引:3
|
作者
Smajic, Miralem [1 ]
Nikolic, Katarina [2 ]
Vujic, Zorica [2 ]
Ahmetovic, Lejla [1 ]
Kuntic, Vesna [3 ]
机构
[1] Univ Tuzla, Fac Pharm, Inst Pharmaceut Chem, Univ 8, Tuzla 75000, Bosnia & Herceg
[2] Univ Belgrade, Fac Pharm, Inst Pharmaceut Chem, Vojvode Stepe 450, Belgrade 11000, Serbia
[3] Univ Belgrade, Fac Pharm, Inst Phys Chem, Vojvode Stepe 450, Belgrade 11000, Serbia
关键词
3D-QSAR; Angiotensin AT(1) receptor blockers; GRIND/ALMOND analysis; Drug design; ANGIOTENSIN RECEPTOR; LIGANDS; BINDING; DERIVATIVES; NONPEPTIDE; AT(2);
D O I
10.1007/s00044-015-1470-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A 3D-QSAR model using the GRIND/ALMOND descriptors has been performed on a set of 49 angiotensin receptor blockers, also known as angiotensin II receptor antagonists, a family of agents that bind to and inhibit the angiotensin II type 1 receptor. The most commonly used chemical probes: DRY (hydrophobic interaction), O (carbonyl oxygen sp(2), hydrogen bond donor), N1 (NH neutral, hydrogen bond acceptor) and TIP (shape descriptor molecular forms) were derived from the GRID molecular interaction fields. A statistical approach was undertaken using the method of partial least squares within the Pentacle program. The results show satisfactory accuracy of the prediction model (RMSEE = 0.239, R-2 = 0.94, Q(2) = 0.85). The V597 (DRY-TIP) and V763 (O-TIP) represent the most significant variables that correlate positively with the activity of the ARBs. Thirty novel structures of ARBs were designed, according to the developed 3D-QSAR model and pharmacophore, what might set the basis for development of new antihypertensive drugs.
引用
下载
收藏
页码:51 / 61
页数:11
相关论文
共 50 条
  • [41] 3D-QSAR studies of saponins
    Gu, Y
    Chen, MB
    Dong, XC
    Chen, HF
    Zeng, BS
    Feng, CL
    Yu, B
    Hui, YZ
    ACTA CHIMICA SINICA, 2000, 58 (12) : 1534 - 1539
  • [42] 3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1
    Sekhar, Y. Nataraja
    Ravikumar, Muttineni
    Nayana, M. Ravi Shashi
    Mallena, Shyam C.
    Kumar, Madala Kishore
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (05) : 1025 - 1034
  • [43] Pharmacophore modeling and 3D-QSAR studies of leucettines as potent Dyrk2 inhibitors
    Anu Bahl
    Prashant Joshi
    Sandip B. Bharate
    Harish Chopra
    Medicinal Chemistry Research, 2014, 23 : 1925 - 1933
  • [44] Pharmacophore modeling and 3D-QSAR studies of leucettines as potent Dyrk2 inhibitors
    Bahl, Anu
    Joshi, Prashant
    Bharate, Sandip B.
    Chopra, Harish
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (04) : 1925 - 1933
  • [45] Pharmacophore modelling, 3D-QSAR and docking study of HIV inhibitor
    Lisina, K., V
    Piramanayagam, Shanmughavel
    INDIAN JOURNAL OF BIOTECHNOLOGY, 2018, 17 (01): : 160 - 175
  • [46] A3 adenosine receptor: Homology modeling and 3D-QSAR studies
    Almerico, Anna Maria
    Tutone, Marco
    Pantano, Licia
    Lauria, Antonino
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2013, 42 : 60 - 72
  • [47] 3D-QSAR analysis of acyl sulfonamides and acyl sulfamides as AT1 selective Angiotensin-II receptor antagonists based on semiemperical AM1 calculations
    Banchhor, Madhuri
    Banchhor, Prakash
    Chaturvedi, S. C.
    ASIAN JOURNAL OF CHEMISTRY, 2008, 20 (01) : 177 - 186
  • [48] 3D-QSAR studies of substituted 1-(3, 3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists
    Yogesh D. Aher
    Avantika Agrawal
    Prasad V. Bharatam
    Prabha Garg
    Journal of Molecular Modeling, 2007, 13 : 519 - 529
  • [49] Molecular modeling and 3D-QSAR studies of indolomorphinan derivatives as kappa opioid antagonists
    Li, W
    Tang, Y
    Zheng, YL
    Qiu, ZB
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (03) : 601 - 610
  • [50] Receptor-guided 3D-QSAR Study of Anilinoquinazolines as RET Receptor Tyrosine Kinase Antagonists
    Bhujbal, Swapnil Pandurang
    Balasubramanian, Pavithra Kuruchi
    Keretsu, Seketoulie
    Cho, Seung Joo
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2019, 40 (03): : 207 - 213